Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ENSG00000294606, described as a "novel transcript, sense intronic to FAM19A5," is annotated as a long non-coding RNA (lncRNA) gene and does not encode a protein or known receptor, enzyme, transporter, or other classical therapeutic target[3]. It is named for its genomic position: it is located within an intron and on the sense strand of the FAM19A5 gene. There is currently no evidence of direct biological function, disease association, or druggability for this particular transcript, nor evidence classifying it as a recognized therapeutic target[3]. This entry may represent incomplete, computational, or uncharacterized annotation data; therefore, it is marked as "incorrect" for use as a target in drug discovery or pharmacological contexts. If you are seeking information about FAM19A5 itself (as a target or protein), please specify, as this entry instead refers to a transcript of unknown function that overlaps with the FAM19A5 gene and is not considered a receptor or other therapeutic target[3].
None known
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Novel transcript, sense intronic to FAM19A5 (ENSG00000294606).